Longview Acquisition Corp. II

Longview Acquisition Corp. II (NYSE: LGV) is a blank-check company sponsored by Glenview Capital Management, the healthcare-focused investment firm behind the broader Longview SPAC franchise. The company completed its initial public offering in 2021, targeting acquisition opportunities in the healthcare and life sciences sector. LGV filed an 8-K with the Securities and Exchange Commission on December 14, 2022, accession number 0001104659-22-126969, reflecting a reportable corporate event during its search for a business combination target. For complete filing history, deal status, sponsor background, and real-time SPAC analytics on Longview Acquisition Corp. II and thousands of other vehicles, sign up for full data access at SpacDesk.